EXCYTE (Beijing) Pharmaceutical Technology Development Co., Ltd.

EXCYTE (Beijing) Pharmaceutical Technology Development Co., Ltd.
  • Home
  • Technology
    全部 Engineering expression platform Antibody Humanization Antibody Affinity Maturation Phage Display Antibody Library Bispecific Antibody CAR-T
  • About Us
    全部 Corporate Honors Introduction Team History
  • Product
    全部 Drug Discovery Scientific research products Project cooperation Alpaca natural nanoantibody phage display library Alpaca antigen injection and alpaca blood collection Antibody customization Antibody humanization maturation of antibody affinity Human natural antibody phage display library YK012 Diagnostic and therapeutic neutralizing antibodies against COVID-19
  • News
  • Job
  • Contact

  1. Home
  2. News

Zhongguancun cutting-edge technology enterprise

2020-09-10 09:58:28 admin 0

It is not easy for 2020 to be a real mouse, and the world will change in 2021. With the footsteps of 2021 quietly coming, Ecotech has ushered in the first gold-lettered signboard of the new year - Zhongguancun cutting-edge technology enterprise.

益科思特(北京)科技医药科技发展有限公司官网


  • Previous : Top 50 of the "Maker Beijing 2020" epidemic prevention and control special competition
  • Next : In May 2020, the article on COVID-19 treatment antibody was published in Cold Spring Harbor of the United States
  • News

为你推荐

  • Nature Major findings: lower affinity agonist antibody is more effective
  • Phase I clinical trial project of YK012 for injection was officially launched
  • The 2022 year-end summary meeting ended successfully
  • The leaders went to the Sino-Science Life Science Industrial Park for investigation
  • Fight against COVID-19 - EXCYTE is in action

版权所有 2017-2026 京ICP备17063430号

5 Kaituo Road, Haidian District, Beijing (Zhongguancun Bio-medicine Park) Room B306-308

133-0121-5426

Powered by  MetInfo  7.5.0